Osiris Therapeutics Stock Forecast

Buy candidate since Oct 30, 2017 Gain 6.38%

The Osiris Therapeutics stock price gained 6.38% on the last trading day (Tuesday, 31st Oct 2017), rising from $4.70 to $5.00. During the last trading day the stock fluctuated 6.81% from a day low at $4.70 to a day high of $5.02. The price has fallen in 6 of the last 10 days but is still up by 15.47% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 47 thousand more shares were traded than the day before. In total, 49 thousand shares were bought and sold for approximately $246.61 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $4.74, a level that may pose a second chance to hit a runner. According to fan-theory $5.72 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

OSIR Signals & Forecast

Mostly positive signals in the chart today. The Osiris Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.83 and $4.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, October 30, 2017, and so far it has risen 6.38%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Osiris Therapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Osiris Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.63 and $4.60. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Osiris Therapeutics finds support just below today's level at $4.63. If this is broken, then the next support from accumulated volume will be at $4.60 and $4.20.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.320 between high and low, or 6.81%. For the last week the stock has had daily average volatility of 3.77%.

Our recommended stop-loss: $4.79 (-4.27%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (OSIR) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Osiris Therapeutics to open at $4.91, and during the day (based on 14 day Average True Range), to move between $4.90 and $5.10, which gives a possible trading interval of +/-$0.206 (+/-4.20%) up or down from last closing price. If Osiris Therapeutics takes out the full calculated possible swing range there will be an estimated 4.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.63 (7.40%) than the resistance at $5.80 (16.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Osiris Therapeutics stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.290 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 1, 2017 - $4.91 ( 1.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk